Marine Compound Discovery Shows Promise of Improved Drug Treatment for COPD Patients

Published Online: Thursday, January 16, 2014
Follow Pharmacy_Times:
University of Florida pharmacy researchers have isolated a compound from blue-green algae that may inhibit the progression of pulmonary disease.

Related Articles
Asthmatics with vitamin D deficiency are significantly more susceptible to acute asthma attacks.
Agave nectar and placebo may be more effective in treating a child’s cough than “watchful waiting” with no treatment at all.
A perceived increase in confirmed cases of enterovirus D68 may be attributable to a faster lab test recently put in place by the US Centers for Disease Control and Prevention.
The FDA today granted breakthrough therapy designation to a new treatment for non-small cell lung cancer patients.
Latest Issues
$auto_registration$